SolarEdge Technologies, Inc.

SolarEdge Technologies designs DC-optimized inverter systems for solar PV — the specific competitor to Enphase in the residential/commercial solar space. The equity is up 62% YTD but sits at 6% of its 52-week range as the post-boom drawdown continues, though a specific policy catalyst has just landed.

• The revenue re-acceleration is real: Q1 revenue grew 41.5% year-over-year to $311M, prior quarters ran 9-96%, gross margins improved to 22% (from single-digits earlier), and Q2 EPS of $0.06 crushed a -$0.02 consensus — the operational recovery is landing, though margins remain negative on operating basis.
• The FCC ban on foreign inverters is the specific catalyst: UBS upgraded to Buy with a $42 target (from $36) framing SEDG as a key beneficiary with ~41% upside on tighter supply, share gains and pricing power — Trump's emergency order banning foreign energy equipment from the grid on national-security grounds compounds the tailwind.
• The valuation reflects the recovery: at 3x sales with negative earnings, SEDG is priced as a story-stock — the FY27 EPS estimate becoming positive is what would trigger a genuine multiple re-rate as the ban catalyzes real US share-gain revenue.
• The short-interest setup adds catalyst-flow: roughly 21% short float means any positive quarter or contract announcement triggers covering pressure — the multi-month recovery from the $30-33 bottom is exactly the setup where policy-plus-shorts converge.

The path if it works is a Nov 4 Q3 print showing continued revenue acceleration plus specific commentary on FCC ban-related market share gains — the tape breaks the coil upward toward the UBS $42 target. What extends the drift is a Q3 with margin compression that would suggest the ban doesn't translate to price/margin improvement; that's when a stock at 6% of its 52-week range extends the drop despite the policy tailwind.